Innovative Digital Therapy Oncomfort's digital sedation platform leverages virtual reality and clinical hypnotherapy, providing a non-pharmacological alternative for pain and anxiety management across various medical procedures, which can appeal to healthcare providers seeking innovative patient care solutions.

Expanding Market Presence With successful launches in Benelux and France, along with partnerships such as Vygon in Europe, Oncomfort demonstrates a growing footprint that offers sales opportunities across multiple European healthcare markets.

Recent Acquisition Advantage The recent acquisition by Hypnovr positions Oncomfort within a broader VR-based therapy ecosystem, creating potential for integrated product bundles and joint market expansion efforts to target hospitals and clinics worldwide.

Strong Funding Support With over $12 million in funding and international awards recognizing innovation and clinical application, Oncomfort has the financial backing and credibility to scale its sales efforts and penetrate new healthcare segments.

Growing Customer Base Having delivered over 30,000 treatments using Sedakit, Oncomfort's proven track record and proven efficacy can be leveraged to build trust with healthcare institutions interested in digital health solutions that reduce reliance on medications.